Immunologic diagnostic and therapeutic aspects of cytomegalovirus, human herpes virus-6, and Epstein-Barr virus disease posttransplantation.
Jacobs
U
U
Department of General Internal Medicine, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
Eis-Hübinger
A
A
Dietrich Miersch
W
W
Klehr
H U
HU
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D016516:CD4-CD8 Ratio; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D006084:Graft Rejection / Q000517:prevention & control; D006566:Herpesviridae Infections / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D004854:Herpesvirus 4, Human; D015654:Herpesvirus 6, Human; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007159:Immunologic Tests; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D016131:Lymphocyte Subsets; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011183:Postoperative Complications; D012189:Retrospective Studies; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3